Skip to main content
Home
  • Home
  • OVER REACTIV8
  • VOOR CLINICI
  • Over Mainstay
  • NIEUWS & EVENEMENTEN
  • VOOR INVESTEERDERS
  • Careers
  • Contact
  • EN
  • FR
  • DE
  • NL
  • US
  • AU
Sub menu▸
  • OVERVIEW
  • Results and Presentations
  • News
  • Governance
  • Share Price
  • Shareholder Information
    • Analysts
    • Registrar
    • Advisors
    • Listing
    • 2016 Placing
    • 2018 Placing
    • 2019 Placing
    • PFIC Status
    • Letter to Shareholders
  • Rule 26 Information
  • Contact Us

Listing Documents

Documents relating to the initial public offering of Mainstay Medical International plc.

  • Intention to Float Announcement 
  • Indicative Price Range Announcement 
  • Pre-Admission Announcement - ESM Schedule One 
  • Total Number of Shares and Voting Rights Announcement 
  • Prospectus 
  • French convenience translation of the Prospectus and further step in 2014 corporate reorganisation announcement 
  • Pricing Statement 
  • Pricing Release 
  • Partial Exercise of the Over-Allotment Option 

© Copyright 2017 Mainstay Medical Limited. Alle rechten voorbehouden.

Footer menu

  • Sitemap
  • Contact
  • Impressum
  • Privacybeleid
  • Algemene voorwaarden
  • Commercial Terms & Conditions

ReActiv8 draagt een CE-markering voor de behandeling van chronische lage rugpijn en is beschikbaar voor verkoop in Europa.

Disclaimer

I am in the United States, Canada, Japan or Australia.

Show